Head and Neck Cancer

• Phase II- Efficacy and Toxicity of Induction Premetremed (Alimta) ans Oxaliplatin (Eloxatin) in patients withLocally Advanced Head &Neck Squamous Cell Cancer

Breast Cancer

• Phase II- Letrolzole plus Tarceva in Post-Menopausal Women w/ER &/or PR+ Metastatic Breast Cancer

Lung Cancer

• Phase II- Multicenter, Open-Label, Trial of PR-104 in Treatment Naïve and Sensitive-relapse Small Cell Lung
• Phase I- Nab-Paclitaxel and Carboplatin with Concurrent Radiation Therapy for Unresectable Stage III Non Small Cell Lung Cancer
• Phase II- Trial of Carboplatin and Abraxane on Two Different Schedules in Patients with Extensive Stage Small Cell Lung Cancer
• Randomized, Double-Blind Study Comparing Aflibercept versus Placebo in patients treated with 2nd line Docetaxel after Failure of 1 Platinum Based Therapy for Locally Advanced or Metastatic Non Small Cell Lung Cancer (OPENING IN JUNE)

Pancreatic Cancer

• Phase II- Multi-center, open-label, Randomized Study Comparing the Efficacy and Safety of S-1 as a Single Agent versus 5FU Bolus for the Treatment of patients with Metastatic Pancreatic Cancer Previously Treated with Gemcitabine-based regimen

Colorectal Cancer

• Phase II- Randomized Study of 7on/ 7 off Capecitabine in Combination with Bevacizumab and either Short course of Irinotecan or Oxaliplatin as First line Treatment for Patients with Metastatic Colorectal Cancer
• Phase III, Randomized Double Blind Placebo Controlled Study of Efficacy of Xaliproden in Preventing the Neurotoxicity of Oxaliplatin in 1st line treatments of patients with Metastatic Colorectal Cancer treated with Oxaliplatin/Leucovorin/5FU.
• Phase II Study of FOLFOX or FOLFURI with AG-013736 or Bevacizumab in Patients with Metastatic Colorectal Cancer after Failure of an Irinotecan or Oxaliplatin-containing First line Regimen (OPENING IN JUNE/JULY)

Renal Cell Cancer

• Phase II Axtinib as a Second-line Therapy for Metastatic Renal Cell Cancer-AXIS Trial (OPENING IN JULY)

CLL

• Study of Weekly Alvocidib in Patients with Previously Treated B-Cell Chronic Lymphocytic Leukemia(CLL) or Prolymphocytic Leukemia(PLL) Arising from CLL(Coming Aug)

 © Copyright 2004, Purchase Cancer Group
 All rights reserved.